T he association of carotid atherosclerosis (carotid intima-media thickness [cIMT] and the presence of carotid plaque) with the risk of stroke in a large cohort of community-dwelling adults with atrial fibrillation (AF) has not been examined. It is unknown whether addition of cIMT and carotid plaque would improve risk prediction of stroke over the CHA 2 DS 2 -VASc (variables age, heart failure, hypertension, diabetes mellitus, myocardial infarction, and peripheral arterial disease) risk score 1 among individuals with AF.
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Statistical Analyses
cIMT was evaluated in quintiles and as a continuous variable. To estimate the association of cIMT and carotid plaque with time to incident ischemic stroke, we calculated hazard ratios and 95% confidence intervals (CIs) using multivariable Cox models. Person-years at risk were calculated from AF ascertainment until date of development of stroke, death, loss to follow-up, or end of follow-up (December 2011), whichever occurred first. The first multivariate model was adjusted for age, sex, race, and field center. The second model additionally adjusted for CHA 2 DS 2 -VASc variables (heart failure, hypertension, diabetes mellitus, coronary heart disease, and peripheral arterial disease). Race was included in the models because AF risk factors, incidence, and outcomes differ by race. 5 We utilized the CHA 2 DS 2 -VASc score just before AF diagnosis as the benchmark to assess the role of arterial indices in enhancing risk prediction for stroke in AF. We considered 4 models: the benchmark alone, addition of cIMT or carotid plaque alone, and addition of both cIMT and carotid plaque. To assess model discrimination, we computed the C-statistic. We also calculated net reclassification improvement, Grønnesby-Borgan statistic, and the integrated discrimination improvement. Statistical analyses were performed with SAS.version 9.3 (SAS Inc, Cary, NC).
Results
Participants who had strokes during follow-up were more likely to be women, black, had traditional atherosclerotic risk factors, higher cIMT, and presence of carotid plaque ( Table 1 ).
Association of cIMT and Carotid Plaque With Ischemic Stroke Risk in AF
There were 81 (11.2%) stroke events occurring among 724 participants with AF during a mean follow-up of 8.5 years ( Figure I in the online-only Data Supplement). Compared with participants in the lowest quintile, the hazard ratio (95% CI) of stroke for those in the highest quintile of cIMT was 2.30 (1.12-4.74), P value for trend=0.005, after adjustment for age, sex, race, and field center ( Figure II in the online-only Data Supplement). This association was attenuated after additional adjustment for CHA 2 DS 2 -VASc variables. Each 1 SD increase in cIMT was associated with a 23% increased risk of stroke. The relationship between cIMT and stroke did not differ by sex (interaction P=0.25) or race (P=0.53; Table 2 ).
Compared with participants without plaque, the presence of plaque was associated with a 56% increased risk of stroke 
Model Discrimination, Calibration, and Reclassification
C-statistic increased from 0.685 (95% CI, 0.623-0.747) for the model including race and CHA 2 DS 2 -VASc variables to 0.698 (95% CI, 0.638-0.759) after addition of both cIMT and plaque information. Addition of both plaque and cIMT to this model resulted in a significant net reclassification improvement, 0.091 (95% CI, 0.012-0.170). Overall, the risk levels for participants reclassified because of cIMT and carotid plaque data were more accurate ( Table I in the online-only Data Supplement; Table 3 ). The integrated discrimination improvement showed improved risk classification after the addition of cIMT and plaque information. The Grønnesby-Borgan statistic also showed good model fit, after the addition of cIMT and plaque information. Overall, the best model for prediction of stroke in AF was one comprising race and CHA 2 DS 2 -VASc variables, with addition of cIMT and plaque information.
Discussion
In this population-based prospective study of participants with incident AF, cIMT and carotid plaque were found to be independent predictors of 10-year ischemic stroke risk in middle-aged adults. The addition of cIMT and carotid plaque information provided incremental predictive value for risk of stroke in adults with AF, over the CHA 2 DS 2 -VASc risk score. Direct evaluation of carotid plaque and cIMT using noninvasive and readily available imaging modalities like carotid ultrasonography may contribute to improvement in risk prediction of stroke in AF over the CHA 2 DS 2 -VASc risk score that uses clinical variables alone.
For patients with intermediate risk of stroke (CHA 2 DS 2 -VASc score of 1), the 2012 ESC guidelines 6 recommend oral anticoagulation; whereas the 2014 American Heart Association/ACC/HRS guidelines recommend no antithrombotic therapy, oral anticoagulant, or aspirin. 7 Hence, there is equipoise in management of these patients. Our findings provide preliminary evidence that carotid ultrasonography may be useful in reclassifying these patients. These results also reinforce the concept that atherosclerosis plays an important role in the cause of stroke in AF.
Strengths of this study include the extensive measurement of covariates, large number of AF cases, >40% women, and inclusion of nonwhite participants. There are however, a few limitations. First, it is possible that nonhospitalized stroke events that were not validated in the study could influence the results. However, the magnitude of any potential underestimation of the rate of stroke is likely to be small (<5%). 8 Second, there may be misclassification of AF. However, prior analysis within the ARIC cohort to determine the validity of hospital discharge diagnoses for AF reported 84% sensitivity and 98% specificity in AF ascertainment. 3 Third, our study population has a mean age of 63 years followed by an 8.5-year mean follow-up. This may limit generalizability to the elderly.
Conclusions
Additional studies are needed to validate these findings in other populations and develop a scoring system that would enhance stroke risk prediction by incorporating cIMT and carotid plaque into the CHA 2 DS 2 -VASc score. Based on a 10-year risk prediction. cIMT is added as per 1 SD of measure. NRI is category based: <5%, 5% to 10%, and >10%. Benchmark: race and CHA 2 DS 2 -VASc variables (age, heart failure, hypertension, diabetes mellitus, myocardial infarction, and peripheral arterial disease). CI indicates confidence interval; cIMT, carotid intima-media thickness; IDI, integrated discrimination improvement; and NRI, net reclassification improvement.
*Results denote the best model for prediction of stroke in atrial fibrillation. 
Supplemental Appendix

Methods
Study Population
The ARIC study is a population-based prospective study of cardiovascular disease (CVD) in a bi-racial cohort of 15,792 participants aged 45 to 64 years at enrollment (1987) (1988) (1989) measurements of the far wall (in 1-mm increments) were attempted. The mean of the mean IMT measurements across these segments of both the right and the left sides was calculated. Trained readers adjudicated plaque presence or absence if two of the following three criteria were met: abnormal wall thickness (defined as cIMT >1.5mm), abnormal shape (protrusion into the lumen, loss of alignment with adjacent arterial wall boundary), and abnormal wall texture (brighter echoes than adjacent boundaries).
Ascertainment of Incident AF and Ischemic Stroke
AF was identified through hospital discharge diagnosis codes, or electrocardiograms (ECG) performed at study visits, when International Classification of Diseases, ninth revision, clinical modification (ICD-9-CM) code 427.31 or 427.32 or ICD-10 code I48, was listed in any position. All study visit ECGs coded by ECG software as AF were visually re-checked by a cardiologist or trained coder to confirm the diagnosis.
Incident stroke events were identified from annual telephone interviews, study visits, surveillance of the ARIC community hospitals for all participants' hospitalizations through December 31, 2011. Hospital reports were abstracted and reviewed if the discharge diagnosis included a cerebrovascular disease code (ICD-9 codes 430 to 438), if a cerebrovascular procedure was mentioned in the discharge summary, or if a CT or MR report showed evidence of cerebrovascular disease.
ARIC adapted the National Survey of Stroke criteria for its stroke definition (1) . A computerized algorithm and physician reviewer independently classified the diagnosis of definite or probable stroke and the stroke subtype, with differences adjudicated by another physician.
Ascertainment of Covariates
Race was based on self-report. Hypertension was defined as use of medication to treat high blood pressure, systolic blood pressure ≥140 mm Hg, or diastolic blood pressure ≥90 mm Hg. Diabetes mellitus was defined as a self-reported physician's diagnosis of diabetes, use of diabetic medications, nonfasting serum glucose levels ≥200 mg/dL, or fasting serum glucose level ≥126 mg/dL. Heart failure at baseline was defined as the reported use of medications to treat heart failure in the previous 2 weeks or the presence of heart failure according to Gothenburg criteria (2); incident heart failure at follow-up visits was defined as the presence of ICD-9-CM code 428 in any hospitalization during follow-up. Prevalent coronary heart disease (CHD)
was defined as self-reported, physician-diagnosed CHD or the presence of a previous myocardial infarction (MI) by ECG.
Questionnaires during study visits assessed self-reported smoking status (current, former, never) and smoking amount. PAD was defined as ankle-brachial index <0.9. During an ultrasound exam, trained and certified sonographers measured ankle and brachial systolic blood pressures with a Dinamap™ 1846 SX automated oscillometric device (Critikon, Inc, Tampa, Florida) using standard protocols. Only one ankle was measured in each participant. Decision as to right or left was made based on a random number displayed on the computer screen. The ABI was then calculated as the average of the two ankle systolic measurements divided by the average of the first two brachial readings (3) . PAD was defined as ankle-brachial index of <0.9.
Statistical analysis
We calculated the net reclassification improvement (NRI) which examines the net effect of adding a marker to the risk prediction scheme (4); values greater than zero indicate improved reclassification. Using Cox-proportional hazards, the 10-
year ischemic stroke risk for each of the models was calculated, and participants were classified into <10%, 10%-20%, and >20% (approximately 1%, 1%-2%, and >2% per year). The number of individuals who changed risk groups (i.e., reclassified after adding arterial indices) was described. We also described the clinical NRI, or the NRI in intermediate risk individuals
(CHA2DS2-VASc of 1), i.e., individuals in which the addition of carotid indices may be of most use. To test the model calibration, we compared the "goodness-of-fit" of the observed and expected number of events within estimated risk decile groups using the Grønnesby-Borgan statistic (5) . Large values of the test statistic (and therefore, small, significant 'p' values) suggest poor model fit. Finally, we estimated the integrated discrimination improvement (IDI) (6) which is the difference in an R 2 -like statistic between the benchmark and augmented models. 
